Page last updated: 2024-08-24

allicin and Diabetic Angiopathies

allicin has been researched along with Diabetic Angiopathies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Gao, W; Li, CL; Li, WJ; Liu, DS; Liu, XH; Ma, CM; Ning, LN; Qiao, Y; Sun, YS	1

Other Studies

1 other study(ies) available for allicin and Diabetic Angiopathies

Article	Year
Allicin alleviates inflammation of diabetic macroangiopathy via the Nrf2 and NF-kB pathway. European journal of pharmacology, 2020, Jun-05, Volume: 876 Topics: Animals; Apoptosis; Blood Glucose; Cell Proliferation; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Disulfides; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Male; Mice, Inbred C57BL; NF-E2-Related Factor 2; NF-kappa B; Streptozocin; Sulfinic Acids	2020

Article

Year

Allicin alleviates inflammation of diabetic macroangiopathy via the Nrf2 and NF-kB pathway.

European journal of pharmacology, 2020, Jun-05, Volume: 876

Topics: Animals; Apoptosis; Blood Glucose; Cell Proliferation; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Disulfides; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Male; Mice, Inbred C57BL; NF-E2-Related Factor 2; NF-kappa B; Streptozocin; Sulfinic Acids

2020